mortality/aging
• mice die between 1 and 8.5 months of age, with a mean age of death of 4.8 +/- 2.6 months
|
growth/size/body
visceromegaly
(
J:90252
)
• mice develop organomegaly and die between 1 and 8.5 months of age
|
neoplasm
• all females have leukemia and/or lymphoma at the time of death
|
• presence of abnormal lymphoblasts in the bone marrow, spleen, and peripheral blood in most mice, suggesting a leukemia-like process
• abnormal lymphoblasts are also are seen in the liver, kidneys, and lungs
• tumors express T-cell markers
• all mice have at least 2 organs affected, with most showing multiorgan involvement
|
• all mice develop lymphoid malignancy at a mean age of 9.6 +/- 2.4 months
(J:90252)
• all mice show lymphoma in the spleen
(J:90252)
• 20 of 23 mice show lymphoma in the thymus
(J:90252)
• 21 of 23 mice show lymphoma in the bone marrow
(J:90252)
• 21 of 24 mice show lymphoma in the lymph nodes
(J:90252)
• 18 of 23 mice show gut-associated lymphoid tissue
(J:90252)
|
|
• all females have leukemia and/or lymphoma at the time of death
(J:121308)
|
• by 2 months of age, uteri are abnormal with mild enlargement and development of early adenosarcoma-like changes which progress to fully developed tumors by 6-12 months of age
• all female founders develop uterine tumors at a mean age of 4.2 +/- 0.6 months
• all third generation females develop uterine tumors at a mean age of 8.1 +/- 2.4 months
• uteri show large, polypoid intracavitary endometrial tumors resembling human uterine adenosarcomas
• tumors are comprised of an overgrowth of endometrial stroma accompanied by benign-appearing endometrial type glands
• however, no metastatic uterine tumors are seen
|
• one female developed multiple nodules of benign-appearing smooth muscle in the myometrium resembling human uterine leiomyomas
|
muscle
• one female developed multiple nodules of benign-appearing smooth muscle in the myometrium resembling human uterine leiomyomas
|
behavior/neurological
• mice show decreased activity with disease progression
|
digestive/alimentary system
• intestines are hyperemic with a thickened mucosa and increased weight at necropsy
• both large and small intestines exhibit increased proliferation, ectopic crypt formation, and polyp formation
|
• 4 mice develop rectal or cervical prolapse
|
• polyp formation in both large and small intestines
|
hematopoietic system
• blood counts show a pronounced leukocytosis
|
immune system
• blood counts show a pronounced leukocytosis
|
reproductive system
• by 2 months of age, uteri are abnormal with mild enlargement and development of early adenosarcoma-like changes which progress to fully developed tumors by 6-12 months of age
• all female founders develop uterine tumors at a mean age of 4.2 +/- 0.6 months
• all third generation females develop uterine tumors at a mean age of 8.1 +/- 2.4 months
• uteri show large, polypoid intracavitary endometrial tumors resembling human uterine adenosarcomas
• tumors are comprised of an overgrowth of endometrial stroma accompanied by benign-appearing endometrial type glands
• however, no metastatic uterine tumors are seen
|
• one female developed multiple nodules of benign-appearing smooth muscle in the myometrium resembling human uterine leiomyomas
|
• endometrial stroma has greatly increased volume with variable degrees of hypercellularity and edema and the epithelial component shows foci of glandular crowding and dilation
|
• 4 mice develop rectal or cervical prolapse
|
• all females are infertile
• however, males exhibit normal fertility
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
lymphoma | DOID:0060058 | J:90252 | ||
T-cell acute lymphoblastic leukemia | DOID:5603 | J:90252 | ||
uterine cancer | DOID:363 | J:121308 |